107 related articles for article (PubMed ID: 26283704)
1. Detection of tumour cells in the bloodstream of patients with uveal melanoma: influence of surgical manipulation on the dissemination of tumour cells in the bloodstream.
Charitoudis G; Schuster R; Joussen AM; Keilholz U; Bechrakis NE
Br J Ophthalmol; 2016 Apr; 100(4):468-72. PubMed ID: 26283704
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
[TBL] [Abstract][Full Text] [Related]
3. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of circulating tumor cells in metastatic uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Thiel E; Foerster MH; Keilholz U
Oncology; 2011; 80(1-2):57-62. PubMed ID: 21625180
[TBL] [Abstract][Full Text] [Related]
5. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction.
Foss AJ; Guille MJ; Occleston NL; Hykin PG; Hungerford JL; Lightman S
Br J Cancer; 1995 Jul; 72(1):155-9. PubMed ID: 7599046
[TBL] [Abstract][Full Text] [Related]
6. Five-year results of prognostic value of tyrosinase in peripheral blood of uveal melanoma patients.
Boldin I; Langmann G; Richtig E; Schwantzer G; Ardjomand N; Wegscheider B; El-Shabrawi Y
Melanoma Res; 2005 Dec; 15(6):503-7. PubMed ID: 16314735
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR.
de Vries TJ; Fourkour A; Punt CJ; van de Locht LT; Wobbes T; van den Bosch S; de Rooij MJ; Mensink EJ; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 May; 80(5-6):883-91. PubMed ID: 10360670
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma.
Brownbridge GG; Gold J; Edward M; MacKie RM
Br J Dermatol; 2001 Feb; 144(2):279-87. PubMed ID: 11251559
[TBL] [Abstract][Full Text] [Related]
9. Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma.
Schittek B; Bodingbauer Y; Ellwanger U; Blaheta HJ; Garbe C
Br J Dermatol; 1999 Jul; 141(1):30-6. PubMed ID: 10417512
[TBL] [Abstract][Full Text] [Related]
10. Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction.
Tobal K; Sherman LS; Foss AJ; Lightman SL
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2622-5. PubMed ID: 8344785
[TBL] [Abstract][Full Text] [Related]
11. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating malignant cells by RT-PCR in long-term clinically disease-free I stage melanoma patients.
Baldi A; Dragonetti E; Battista T; Groeger AM; Esposito V; Baldi G; Santini D
Anticancer Res; 2000; 20(5C):3923-8. PubMed ID: 11268478
[TBL] [Abstract][Full Text] [Related]
13. Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanoma.
Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Davidson BS; Sussman JJ; Edwards MJ; Martin RC; Lewis AM; Stromberg AJ; Conrad AJ; Hagendoorn L; Albrecht J; McMasters KM
J Clin Oncol; 2006 Jun; 24(18):2849-57. PubMed ID: 16782924
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma.
Samija I; Lukac J; Marić-Brozić J; Buljan M; Alajbeg I; Kovacević D; Situm M; Kusić Z
Melanoma Res; 2010 Aug; 20(4):293-302. PubMed ID: 20357686
[TBL] [Abstract][Full Text] [Related]
15. [Detection of circulating malignant cells in patients with uveal melanoma].
Fernandes BF; Antecka E; dos Passos G; Burnier MN
Arq Bras Oftalmol; 2007; 70(4):593-8. PubMed ID: 17906753
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the molecular detection of melanoma cells circulating in the peripheral blood in melanoma patients.
Konstantopoulos K; Psatha M; Kalotychou V; Frangia N; Ioannovits I; Meletis I; Loukopoulos D
Panminerva Med; 2001 Jun; 43(2):109-13. PubMed ID: 11449181
[TBL] [Abstract][Full Text] [Related]
17. Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction.
Keilholz U; Goldin-Lang P; Bechrakis NE; Max N; Letsch A; Schmittel A; Scheibenbogen C; Heufelder K; Eggermont A; Thiel E
Clin Cancer Res; 2004 Mar; 10(5):1605-12. PubMed ID: 15014010
[TBL] [Abstract][Full Text] [Related]
18. Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.
Suesskind D; Ulmer A; Schiebel U; Fierlbeck G; Spitzer B; Spitzer MS; Bartz-Schmidt KU; Grisanti S
Acta Ophthalmol; 2011 Feb; 89(1):17-24. PubMed ID: 21272286
[TBL] [Abstract][Full Text] [Related]
19. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
[TBL] [Abstract][Full Text] [Related]
20. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
